Annual CFO
-$15.20 M
+$18.41 M+54.78%
December 31, 2023
Summary
- As of February 10, 2025, TXG annual cash flow from operations is -$15.20 million, with the most recent change of +$18.41 million (+54.78%) on December 31, 2023.
- During the last 3 years, TXG annual CFO has risen by +$202.70 million (+93.03%).
- TXG annual CFO is now -143.89% below its all-time high of $34.63 million, reached on December 31, 2019.
Performance
TXG Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$21.64 M
+$14.14 M+188.70%
September 30, 2024
Summary
- As of February 10, 2025, TXG quarterly cash flow from operations is $21.64 million, with the most recent change of +$14.14 million (+188.70%) on September 30, 2024.
- Over the past year, TXG quarterly CFO has increased by +$46.95 million (+185.52%).
- TXG quarterly CFO is now -15.98% below its all-time high of $25.76 million, reached on December 31, 2023.
Performance
TXG Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$39.17 M
+$46.95 M+603.79%
September 30, 2024
Summary
- As of February 10, 2025, TXG TTM cash flow from operations is $39.17 million, with the most recent change of +$46.95 million (+603.79%) on September 30, 2024.
- Over the past year, TXG TTM CFO has increased by +$66.40 million (+243.84%).
- TXG TTM CFO is now at all-time high.
Performance
TXG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TXG Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +54.8% | +185.5% | +243.8% |
3 y3 years | +93.0% | +272.8% | +283.3% |
5 y5 years | +80.1% | +223.0% | +13.1% |
TXG Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +54.8% | -16.0% | +185.5% | at high | +167.3% |
5 y | 5-year | -143.9% | +93.0% | -16.0% | +116.6% | at high | +117.8% |
alltime | all time | -143.9% | +93.0% | -16.0% | +116.6% | at high | +117.8% |
10x Genomics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $21.64 M(+188.7%) | $39.17 M(-603.8%) |
Jun 2024 | - | $7.50 M(-147.7%) | -$7.78 M(-71.0%) |
Mar 2024 | - | -$15.72 M(-161.0%) | -$26.80 M(+76.3%) |
Dec 2023 | -$15.20 M(-54.8%) | $25.76 M(-201.8%) | -$15.20 M(-44.2%) |
Sep 2023 | - | -$25.30 M(+119.5%) | -$27.23 M(+137.0%) |
Jun 2023 | - | -$11.53 M(+179.4%) | -$11.49 M(-32.1%) |
Mar 2023 | - | -$4.13 M(-130.1%) | -$16.93 M(-49.6%) |
Dec 2022 | -$33.61 M(+57.2%) | $13.72 M(-243.5%) | -$33.61 M(-19.1%) |
Sep 2022 | - | -$9.56 M(-43.6%) | -$41.52 M(-28.6%) |
Jun 2022 | - | -$16.96 M(-18.5%) | -$58.18 M(+52.7%) |
Mar 2022 | - | -$20.80 M(-458.3%) | -$38.09 M(+78.2%) |
Dec 2021 | -$21.37 M | $5.80 M(-122.1%) | -$21.37 M(-86.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$26.22 M(-940.3%) | -$157.35 M(-15.7%) |
Jun 2021 | - | $3.12 M(-176.4%) | -$186.77 M(-14.9%) |
Mar 2021 | - | -$4.08 M(-96.9%) | -$219.40 M(+0.7%) |
Dec 2020 | -$217.90 M(-729.3%) | -$130.18 M(+134.0%) | -$217.90 M(+168.9%) |
Sep 2020 | - | -$55.63 M(+88.5%) | -$81.02 M(+645.5%) |
Jun 2020 | - | -$29.52 M(+1045.9%) | -$10.87 M(-147.8%) |
Mar 2020 | - | -$2.58 M(-138.4%) | $22.73 M(-34.3%) |
Dec 2019 | $34.63 M(-145.3%) | $6.70 M(-53.9%) | $34.63 M(+24.0%) |
Sep 2019 | - | $14.53 M(+255.8%) | $27.93 M(+108.4%) |
Jun 2019 | - | $4.08 M(-56.2%) | $13.40 M(+43.8%) |
Mar 2019 | - | $9.32 M | $9.32 M |
Dec 2018 | -$76.41 M(+614.2%) | - | - |
Dec 2017 | -$10.70 M | - | - |
FAQ
- What is 10x Genomics annual cash flow from operations?
- What is the all time high annual CFO for 10x Genomics?
- What is 10x Genomics annual CFO year-on-year change?
- What is 10x Genomics quarterly cash flow from operations?
- What is the all time high quarterly CFO for 10x Genomics?
- What is 10x Genomics quarterly CFO year-on-year change?
- What is 10x Genomics TTM cash flow from operations?
- What is the all time high TTM CFO for 10x Genomics?
- What is 10x Genomics TTM CFO year-on-year change?
What is 10x Genomics annual cash flow from operations?
The current annual CFO of TXG is -$15.20 M
What is the all time high annual CFO for 10x Genomics?
10x Genomics all-time high annual cash flow from operations is $34.63 M
What is 10x Genomics annual CFO year-on-year change?
Over the past year, TXG annual cash flow from operations has changed by +$18.41 M (+54.78%)
What is 10x Genomics quarterly cash flow from operations?
The current quarterly CFO of TXG is $21.64 M
What is the all time high quarterly CFO for 10x Genomics?
10x Genomics all-time high quarterly cash flow from operations is $25.76 M
What is 10x Genomics quarterly CFO year-on-year change?
Over the past year, TXG quarterly cash flow from operations has changed by +$46.95 M (+185.52%)
What is 10x Genomics TTM cash flow from operations?
The current TTM CFO of TXG is $39.17 M
What is the all time high TTM CFO for 10x Genomics?
10x Genomics all-time high TTM cash flow from operations is $39.17 M
What is 10x Genomics TTM CFO year-on-year change?
Over the past year, TXG TTM cash flow from operations has changed by +$66.40 M (+243.84%)